Concepedia

Dahai Xue

DX

8

Publications

1.5K

Citations

8

H-Index

2003

Active since

Affiliations

United States Military Academy(Current)

Merck & Co., Inc., Rahway, NJ, USA (United States)

Dana-Farber Cancer Institute

Institut Gustave Roussy

University of California, Los Angeles

Dahai Xue is an author at United States Military Academy specializing in medicine, oncology, and tumor immunology.

Top concepts

Publications per year

2003–2016

8

Publications

8

Evaluation of Immune-Related Response Criteria and RECIST v1.1 in Patients With Advanced Melanoma Treated With Pembrolizumab

F. Stephen Hodi, Wen-Jen Hwu, Richard Kefford et al. · Journal of Clinical Oncology · 2016 · 742 citations · Full text

Sorafenib (BAY 43-9006) inhibits tumor growth and vascularization and induces tumor apoptosis and hypoxia in RCC xenograft models

Yong S. Chang, Jalila Adnane, Pamela A. Trail et al. · Cancer Chemotherapy and Pharmacology · 2006 · 462 citations

, , +10

A lupus-like syndrome develops in mice lacking the Ro 60-kDa protein, a major lupus autoantigen

Dahai Xue, Hong Shi, James D. Smith et al. · Proceedings of the National Academy of Sciences · 2003 · 150 citations · Full text

Evaluation of immune-related response criteria (irRC) in patients (pts) with advanced melanoma (MEL) treated with the anti-PD-1 monoclonal antibody MK-3475.

F. Stephen Hodi, Antoni Ribas, Adil Daud et al. · Journal of Clinical Oncology · 2014 · 40 citations

, , +22

Development and optimization of a high-throughput micro-computed tomography imaging method incorporating a novel analysis technique to evaluate bone mineral density of arthritic joints in a rodent model of collagen induced arthritis

Raquel Sevilla, Francisco Cruz, Chi‐Sung Chiu et al. · Bone · 2014 · 27 citations · Full text

, , +19

Rows per page

1–5 of 8